Endo Pharmaceuticals Solutions Inc - Malvern, Pennsylvania 19355

Endo Pharmaceuticals Solutions Inc is categorized under in Malvern, PA .

Business Name: Endo Pharmaceuticals Solutions Inc
Contact Person: David P Holveck
Address: 1400 Atwater Drive, Malvern, Pennsylvania 19355
Phone Number: (484) 216-0000
Annual Revenue (USD): $50.000.000 to $99.999.999
Founding Year: 2009
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Janssen Biotech Inc - Malvern, PA 19355
Crixmor LLC - Malvern, PA 19355
Recro Pharma Inc - Malvern, PA 19355
Janssen Biotech Inc - Malvern, PA 19355
DermAvance Pharmaceuticals - Malvern, PA 19355
Viropharma Incorporated - Malvern, PA 19355
Janssen Biotech Inc - Malvern, PA 19355
Janssen Biotech - Malvern, PA 19355
Lazarus Therapeutics Inc - Malvern, PA 19355
Vicept Therapeutics Inc - Malvern, PA 19355
Cephalon International Holdings Inc - Malvern, PA 19355
Promedior Inc - Malvern, PA 19355
Fred Oakes - Malvern, PA 19355
Endo Pharmaceuticals Inc - Malvern, PA 19355
Teva Pharmaceuticals USA Inc - Malvern, PA 19355
Micron Technologies - Malvern, PA 19355
Qilu Pharma Inc - Malvern, PA 19355
Zeomedix Inc - Malvern, PA 19355

The company Endo Pharmaceuticals Solutions Inc provides BOTH services in the form of from its headquarters in Pennsylvania. 1 to 4 employees work for Endo Pharmaceuticals Solutions Inc, and the business now earns $50.000.000 to $99.999.999 per annum.

Endo Pharmaceuticals Solutions Inc was launched in 2009 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Endo Pharmaceuticals Solutions Inc, please call David P Holveck with the phone number (484) 216-0000 or visit its headquarters at 1400 Atwater Drive in Malvern, Pennsylvania 19355.

The location of the headquarters can also be found using the coordinates 40.071563,-75.527091. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.